Clinical Trial Supplies Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 3.18 Billion
CAGR (2026-2031)	7.76%
Fastest Growing Segment	Pharmaceutical
Largest Market	North America
Market Size (2031)	USD 4.98 Billion

Market Overview

The Global Clinical Trial Supplies Market will grow from USD 3.18 Billion in 2025 to USD 4.98 Billion by 2031 at a 7.76% CAGR. Clinical trial supplies refer to the comprehensive range of investigational medicinal products, medical devices, and ancillary materials such as testing kits and packaging required for compliant clinical studies. The market is primarily supported by the rising volume of global clinical trials and increasing research and development expenditures within the biopharmaceutical sector. Additionally, the growing focus on orphan drugs and biologics necessitates specialized logistics and handling, further driving the demand for robust and secure supply chain solutions.

However, the market faces a significant challenge regarding the complexity of cold chain management, particularly for temperature-sensitive biologics that demand strict environmental controls throughout transport. Regulatory fragmentation across different regions also creates compliance hurdles that can disrupt supply timelines and increase operational costs. According to the 'European Federation of Pharmaceutical Industries and Associations', in '2024', 'the research-based pharmaceutical industry invested an estimated 55,000 million euros in research and development in Europe', underscoring the critical need for efficient supply chain infrastructure to support this substantial investment.

Key Market Drivers

Escalating Pharmaceutical and Biopharmaceutical R&D Expenditure serves as a primary catalyst propelling the Global Clinical Trial Supplies Market. As life science companies aggressively pursue novel therapies for chronic and rare diseases, the financial commitment to discovery necessitates a parallel increase in the procurement of investigational medicinal products and ancillary materials. This intensified spending directly correlates with the need for rigorous supply chain logistics to manage the flow of materials across global study sites. Underscoring this trend, according to Roche, January 2025, in the 'Finance Report 2024', the company's research and development expenditure reached 'CHF 13.0 billion', reflecting the substantial capital allocated to advancing therapeutic pipelines which inevitably requires extensive clinical supply support.

Simultaneously, the market is being driven by the Increasing Volume of Registered Clinical Trials Worldwide, which exponentially expands the operational scope for supply vendors. This surge in study volume, particularly involving complex biologics, demands robust infrastructure to ensure product integrity and timely delivery to diverse geographic locations. According to the National Institutes of Health, April 2025, in the article 'ClinicalTrials.gov: A 25-Year Journey to a Half-Million Registered Studies', the milestone of the '500,000th' clinical study posted on the registry was achieved in 2024, highlighting the sheer scale of active research requiring supply management. To address these growing logistical demands, according to Cencora, November 2025, in the 'Cencora Announces $1 Billion Investment' press release, the company plans to invest '$1 billion' through 2030 to bolster and expand its pharmaceutical distribution network, ensuring capacity for future clinical supply needs.

Download Free Sample Report

Key Market Challenges

The complexity of cold chain management stands as a formidable barrier to the progression of the global clinical trial supplies market. As the industry increasingly shifts toward biologics and orphan drugs, the requirement for strict environmental controls creates a fragile logistical network. These temperature-sensitive products demand uninterrupted refrigeration or freezing from manufacturing to patient administration. Any thermal excursion during transit can compromise the efficacy of investigational medicinal products, leading to substantial financial losses and critical delays in study timelines. This vulnerability forces companies to absorb high costs for specialized packaging and monitoring, which strains operational budgets and impedes the market’s ability to scale efficiently in emerging regions with less established infrastructure.

The pressure on these supply chains is intensified by the volume of sensitive therapies currently in the research pipeline. According to the 'Pharmaceutical Research and Manufacturers of America', in '2024', 'there were more than 8,000 medicines in clinical development' globally. A significant proportion of these candidates are biologics that necessitate rigorous temperature maintenance. The logistical burden of securing such a vast number of sensitive shipments increases the risk of product wastage. Consequently, the high probability of supply chain failure in complex environments limits the expansion of clinical trials into new territories, thereby directly hampering the overall growth potential of the supplies market.

Key Market Trends

The Shift Toward Decentralized Clinical Trial (DCT) Supply Logistics is restructuring the market by moving the point of care from traditional investigator sites to patients' homes. This model necessitates agile supply chains capable of executing direct-to-patient deliveries while maintaining strict temperature controls and chain of custody. Logistics providers are consequently establishing hyper-local distribution hubs to support this dispersed framework, ensuring protocol adherence outside clinical settings. Validating this focus, according to DHL Group, April 2025, in the 'DHL Group to Invest EUR 2 Billion by 2030 in DHL Health Logistics' press release, the company committed '€2 billion' to enhance its life sciences logistics capabilities, specifically targeting the demand for specialized services in complex study designs.

Simultaneously, the Integration of Artificial Intelligence for Demand Forecasting is optimizing inventory management through predictive analytics. By processing datasets like enrollment rates and consumption patterns, AI algorithms accurately predict supply needs, reducing drug wastage and preventing stockouts. This allows sponsors to dynamically adjust distribution strategies to align with real-time requirements, ensuring materials are available precisely when needed. Exemplifying this trend, according to Thermo Fisher Scientific, October 2025, in the 'Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI' press release, the company embedded artificial intelligence across its PPD clinical research business to 'improve the cycle time' of clinical trials and accelerate drug development.

Segmental Insights

The pharmaceutical segment currently represents the fastest-growing category within the global clinical trial supplies market due to intensifying research and development activities focused on novel therapeutics. This rapid expansion is primarily driven by the increasing prevalence of chronic conditions which necessitates continuous innovation in small molecule drug discovery. Furthermore, stringent safety guidelines established by regulatory entities such as the U.S. Food and Drug Administration require precise supply chain management and packaging solutions to ensure study integrity. Consequently, the escalating volume of late-stage clinical studies directly accelerates the demand for pharmaceutical trial supplies.

Regional Insights

North America maintains the leading position in the global clinical trial supplies market, primarily due to the high concentration of pharmaceutical and biotechnology enterprises within the United States. This regional dominance is driven by substantial investment in drug development and a supportive research ecosystem. Additionally, the U.S. Food and Drug Administration (FDA) provides a structured regulatory environment that governs the safety and efficacy of clinical studies, ensuring strict compliance standards. The strong presence of contract research organizations further accelerates demand for supply chain management, ensuring the continuous availability of trial materials across this key market.

Recent Developments

In November 2024, the Almac Group confirmed that its clinical supply facility in Singapore had secured Good Manufacturing Practice (GMP) certification. This regulatory milestone allowed the site to provide comprehensive clinical supply chain services, including secondary packaging and labeling, directly from the Asia-Pacific region. The certification followed a significant investment to enhance the facility's cold chain capabilities, ensuring the secure handling of temperature-sensitive biological products. This development strengthened the company’s ability to support regional and global clinical trials by offering localized supply chain solutions for pharmaceutical and biotechnology sponsors.
In September 2024, PCI Pharma Services announced a major investment of over $365 million to expand its clinical and commercial supply infrastructure in the United States and Europe. This initiative included the development of a new Center of Excellence in Rockford, Illinois, dedicated to the assembly and packaging of advanced drug delivery systems such as injectables. The investment also funded new facilities in Dublin, Ireland, to enhance temperature-controlled storage and packaging capabilities. These expansions were intended to support the growing market demand for complex therapy handling and global clinical trial distribution.
In July 2024, Catalent announced the completion of a $25 million expansion at its clinical supply facility in Schorndorf, Germany. This development increased the site’s footprint by approximately 32,000 square feet, adding significant capacity for the storage and handling of clinical trial materials at controlled room temperatures. The project also created space for a new, fully automated bottle filling line and a dedicated area for the company’s demand-led supply service. These enhancements were designed to meet growing customer demand for comprehensive clinical packaging and temperature-controlled logistics solutions in the European market.
In July 2024, Thermo Fisher Scientific expanded its global clinical trial supply network by opening a new ultra-cold facility in Bleiswijk, the Netherlands. This site was established to support the development of advanced therapies, including cell and gene treatments, by providing specialized storage and logistics capabilities. The company also inaugurated a state-of-the-art innovation lab in Center Valley, Pennsylvania, during the same period. These strategic additions aimed to accelerate drug development timelines for pharmaceutical and biotech clients by addressing complex supply chain challenges and improving the efficiency of clinical research operations.

Key Market Players

Thermo Fisher Scientific Inc.
Almac Group
Novo Holdings A/S
Marken LLP
PCI Pharma Services
Sharp Services LLC
Cencora, Inc.
Myonex LLC
Parexel International Corporation
ICON Plc

By Clinical Phase	By Product & Services	By Therapeutic Use	By End User	By Region
Phase I Phase II Phase III Others	Manufacturing Storage & Distribution Supply Chain Management	Oncology CNS Diseases Cardiovascular Diseases Infectious Disease Metabolic Disorders Others	Pharmaceutical Biologics Medical device Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Clinical Trial Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Supplies Market, By Clinical Phase:

Phase I
Phase II
Phase III
Others

Clinical Trial Supplies Market, By Product & Services:

Manufacturing
Storage & Distribution
Supply Chain Management

Clinical Trial Supplies Market, By Therapeutic Use:

Oncology
CNS Diseases
Cardiovascular Diseases
Infectious Disease
Metabolic Disorders
Others

Clinical Trial Supplies Market, By End User:

Pharmaceutical
Biologics
Medical device
Others

Clinical Trial Supplies Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Supplies Market.

Available Customizations:

Global Clinical Trial Supplies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Clinical Trial Supplies Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Trial Supplies Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Clinical Phase (Phase I, Phase II, Phase III, Others)

5.2.2. By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management)

5.2.3. By Therapeutic Use (Oncology, CNS Diseases, Cardiovascular Diseases, Infectious Disease, Metabolic Disorders, Others)

5.2.4. By End User (Pharmaceutical, Biologics, Medical device, Others)

5.2.5. By Region

5.2.6. By Company (2025)

5.3. Market Map

6. North America Clinical Trial Supplies Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Clinical Phase

6.2.2. By Product & Services

6.2.3. By Therapeutic Use

6.2.4. By End User

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Clinical Trial Supplies Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Clinical Phase

6.3.1.2.2. By Product & Services

6.3.1.2.3. By Therapeutic Use

6.3.1.2.4. By End User

6.3.2. Canada Clinical Trial Supplies Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Clinical Phase

6.3.2.2.2. By Product & Services

6.3.2.2.3. By Therapeutic Use

6.3.2.2.4. By End User

6.3.3. Mexico Clinical Trial Supplies Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Clinical Phase

6.3.3.2.2. By Product & Services

6.3.3.2.3. By Therapeutic Use

6.3.3.2.4. By End User

7. Europe Clinical Trial Supplies Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Clinical Phase

7.2.2. By Product & Services

7.2.3. By Therapeutic Use

7.2.4. By End User

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Clinical Trial Supplies Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Clinical Phase

7.3.1.2.2. By Product & Services

7.3.1.2.3. By Therapeutic Use

7.3.1.2.4. By End User

7.3.2. France Clinical Trial Supplies Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Clinical Phase

7.3.2.2.2. By Product & Services

7.3.2.2.3. By Therapeutic Use

7.3.2.2.4. By End User

7.3.3. United Kingdom Clinical Trial Supplies Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Clinical Phase

7.3.3.2.2. By Product & Services

7.3.3.2.3. By Therapeutic Use

7.3.3.2.4. By End User

7.3.4. Italy Clinical Trial Supplies Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Clinical Phase

7.3.4.2.2. By Product & Services

7.3.4.2.3. By Therapeutic Use

7.3.4.2.4. By End User

7.3.5. Spain Clinical Trial Supplies Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Clinical Phase

7.3.5.2.2. By Product & Services

7.3.5.2.3. By Therapeutic Use

7.3.5.2.4. By End User

8. Asia Pacific Clinical Trial Supplies Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Clinical Phase

8.2.2. By Product & Services

8.2.3. By Therapeutic Use

8.2.4. By End User

8.2.5. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Clinical Trial Supplies Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Clinical Phase

8.3.1.2.2. By Product & Services

8.3.1.2.3. By Therapeutic Use

8.3.1.2.4. By End User

8.3.2. India Clinical Trial Supplies Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Clinical Phase

8.3.2.2.2. By Product & Services

8.3.2.2.3. By Therapeutic Use

8.3.2.2.4. By End User

8.3.3. Japan Clinical Trial Supplies Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Clinical Phase

8.3.3.2.2. By Product & Services

8.3.3.2.3. By Therapeutic Use

8.3.3.2.4. By End User

8.3.4. South Korea Clinical Trial Supplies Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Clinical Phase

8.3.4.2.2. By Product & Services

8.3.4.2.3. By Therapeutic Use

8.3.4.2.4. By End User

8.3.5. Australia Clinical Trial Supplies Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Clinical Phase

8.3.5.2.2. By Product & Services

8.3.5.2.3. By Therapeutic Use

8.3.5.2.4. By End User

9. Middle East & Africa Clinical Trial Supplies Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Clinical Phase

9.2.2. By Product & Services

9.2.3. By Therapeutic Use

9.2.4. By End User

9.2.5. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Clinical Trial Supplies Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Clinical Phase

9.3.1.2.2. By Product & Services

9.3.1.2.3. By Therapeutic Use

9.3.1.2.4. By End User

9.3.2. UAE Clinical Trial Supplies Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Clinical Phase

9.3.2.2.2. By Product & Services

9.3.2.2.3. By Therapeutic Use

9.3.2.2.4. By End User

9.3.3. South Africa Clinical Trial Supplies Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Clinical Phase

9.3.3.2.2. By Product & Services

9.3.3.2.3. By Therapeutic Use

9.3.3.2.4. By End User

10. South America Clinical Trial Supplies Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Clinical Phase

10.2.2. By Product & Services

10.2.3. By Therapeutic Use

10.2.4. By End User

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Clinical Trial Supplies Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Clinical Phase

10.3.1.2.2. By Product & Services

10.3.1.2.3. By Therapeutic Use

10.3.1.2.4. By End User

10.3.2. Colombia Clinical Trial Supplies Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Clinical Phase

10.3.2.2.2. By Product & Services

10.3.2.2.3. By Therapeutic Use

10.3.2.2.4. By End User

10.3.3. Argentina Clinical Trial Supplies Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Clinical Phase

10.3.3.2.2. By Product & Services

10.3.3.2.3. By Therapeutic Use

10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Clinical Trial Supplies Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Thermo Fisher Scientific Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Almac Group

15.3. Novo Holdings A/S

15.4. Marken LLP

15.5. PCI Pharma Services

15.6. Sharp Services LLC

15.7. Cencora, Inc.

15.8. Myonex LLC

15.9. Parexel International Corporation

15.10. ICON Plc

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Clinical Trial Supplies Market in 2025?

Which is the dominating region in the Global Clinical Trial Supplies Market?

Which is the fastest growing segment in the Global Clinical Trial Supplies Market?

What is the expected growth rate of the Global Clinical Trial Supplies Market?